Crinetics Pharmaceuticals, Inc. (CRNX) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 79.92M USD | Liabilities, Current |
| Cash and equivalents | 55.50M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current |
| Customer receivables | 11.96M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 3.49M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $79.92M | $55.50M | (m) | $11.96M | $3.49M | (m) |
| 2026-03-31 | (m) | $71.09M | $114.34M | (m) | $5.68M | $3.06M | (m) |
| 2025-12-31 | (m) | $85.07M | $101.54M | (m) | $592.00K | $2.02M | (m) |
| 2025-09-30 | (m) | $74.16M | $110.90M | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $68.40M | $53.73M | $357.75M | (m) | (m) | (m) |
| 2025-03-31 | (m) | $57.31M | $94.57M | $273.93M | (m) | (m) | (m) |
| 2024-12-31 | (m) | $59.68M | $264.55M | $232.92M | (m) | (m) | (m) |
| 2024-09-30 | (m) | $53.56M | $317.27M | $40.80M | (m) | (m) | (m) |
| 2024-06-30 | (m) | $54.38M | $302.16M | $350.84M | (m) | (m) | (m) |
| 2024-03-31 | (m) | $51.77M | $395.92M | $205.25M | (m) | (m) | (m) |
| 2023-12-31 | (m) | $43.94M | $54.90M | $74.09M | (m) | (m) | (m) |
| 2023-09-30 | (m) | $40.46M | $142.79M | $307.14M | (m) | (m) | (m) |
| 2023-06-30 | (m) | $32.61M | $39.55M | $167.85M | (m) | (m) | (m) |
| 2023-03-31 | (m) | $26.32M | $41.19M | $209.05M | (m) | (m) | (m) |
| 2022-12-31 | (m) | $27.72M | $32.67M | $278.64M | (m) | (m) | (m) |
| 2022-09-30 | (m) | $24.56M | $30.91M | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $26.11M | $62.29M | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $20.26M | $145.55M | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $15.99M | $200.69M | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $12.44M | $161.54M | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $11.92M | $178.77M | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $10.26M | $105.58M | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $10.49M | $93.09M | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $8.83M | $117.82M | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $9.87M | $160.81M | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $10.76M | $50.92M | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $8.34M | $40.33M | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $7.88M | $66.58M | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $7.75M | $59.72M | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $8.82M | $62.83M | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $7.92M | $44.97M | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | $5.51M | $169.65M | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $5.64M | $68.41M | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $897.00K | $14.19M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.